Pancreatic cancer growth is inhibited by blockade of VEGF-RII.

Büchler, Peter; Reber, Howard A; Ullrich, Axel; Shiroiki, Mark; Roth, Mendel; Büchler, Markus W; Lavey, Robert S; Friess, Helmut; Hines, Oscar J

Büchler, Peter; Reber, Howard A; Ullrich, Axel; Shiroiki, Mark; Roth, Mendel; Büchler, Markus W; Lavey, Robert S; Friess, Helmut; Hines, Oscar J.

Affiliation

Büchler P; Department of Surgery, UCLA School of Medicine, University of California-Los Angeles, 10833 Le Conte, Los Angeles, CA 90095-6904, USA.

Surgery ; 134(5): 772-82, 2003 Nov.

Article in En | MEDLINE | ID: mdl-14639356

Subject(s)

Genetic Therapy; Neovascularization, Pathologic/prevention & control; Pancreatic Neoplasms/therapy; Vascular Endothelial Growth Factor Receptor-2/antagonists & inhibitors; Animals; Cell Line, Tumor; Humans; Male; Mice; Mice, Inbred BALB C; Mice, Nude; NIH 3T3 Cells; Pancreatic Neoplasms/blood supply; Pancreatic Neoplasms/pathology; Retroviridae/genetics; Vascular Endothelial Growth Factor A/analysis; Vascular Endothelial Growth Factor Receptor-2/analysis; Vascular Endothelial Growth Factor Receptor-2/genetics

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Pancreatic Neoplasms / Genetic Therapy / Vascular Endothelial Growth Factor Receptor-2 / Neovascularization, Pathologic Type of study: Prognostic_studies Limits: Animals / Humans / Male Language: En Journal: Surgery Year: 2003 Document type: Article Affiliation country: United States Country of publication: United States

Search on Google

Add to My VHL

XML

PubMed Links